Combining BPC-157 and TB-500 is one of the most effective research peptide protocols for tendon healing, with many users in Canada reporting significant improvement within 4 to 6 weeks. A typical cycle uses 250-500 mcg of BPC-157 daily and 2.5-5 mg of TB-500 twice weekly for 4 to 8 weeks. This article explains the exact dosing, timing, and expected results for a BPC-157 TB-500 cycle aimed at tendon repair.
Why Combine BPC-157 and TB-500 for Tendon Healing
BPC-157 and TB-500 work through different but complementary mechanisms. BPC-157, a pentadecapeptide derived from gastric juice, promotes angiogenesis and accelerates fibroblast migration to the injury site. TB-500, a synthetic fragment of thymosin beta-4, upregulates actin and cell migration while reducing inflammation. Together they create a stronger healing environment than either peptide alone.
Tendons have poor blood supply and slow cellular turnover. BPC-157 increases blood vessel formation, while TB-500 recruits stem cells and modulates the inflammatory response. This dual action is why many researchers consider the BPC-157 TB-500 cycle the gold standard for tendon injuries like Achilles tendinopathy, rotator cuff strains, and tennis elbow.
BPC-157 Dosage for Tendon Healing
The most common BPC-157 dosage for tendon healing is 250-500 mcg per day, split into one or two subcutaneous injections near the injury site. For localized tendon issues, injecting as close to the affected area as safely possible may improve outcomes, though systemic effects occur regardless of injection site.
Start with 250 mcg once daily for the first week to assess tolerance. If no adverse effects occur, increase to 250 mcg twice daily or a single 500 mcg dose. Some protocols use up to 1 mg daily for severe injuries, but this is less common and not clearly more effective. A 5 mg vial of BPC-157 reconstituted with 2 mL of bacteriostatic water yields a concentration of 2.5 mg/mL, so a 250 mcg dose equals 0.1 mL (10 units on an insulin syringe).
For more details on sourcing BPC-157 in Quebec, see our guide on buying BPC-157 5mg in Quebec with reliable suppliers.
TB-500 Dosage and Schedule
TB-500 has a longer half-life than BPC-157, so it is dosed less frequently. The standard TB-500 dosage for tendon healing is 2.5-5 mg twice per week, with injections spaced 3-4 days apart. A common schedule is Monday and Thursday. Each injection can be split into multiple smaller injections around the injury if desired, but a single subcutaneous or intramuscular injection is sufficient.
For a 10 mg vial reconstituted with 2 mL of bacteriostatic water, a 2.5 mg dose equals 0.5 mL (50 units). Start at 2.5 mg twice weekly for the first two weeks, then consider increasing to 5 mg twice weekly if healing is slower than expected. Total weekly TB-500 dose typically ranges from 5 to 10 mg. The cycle length for TB-500 is usually 4 to 6 weeks, after which a maintenance phase of 2.5 mg once weekly may be used for another 2 to 4 weeks.
If you are in Quebec and want a detailed TB-500 dosing guide, read our article on TB-500 mcg dosage for tissue repair in Quebec.
Full BPC-157 TB-500 Cycle Protocol
Here is a complete 6-week BPC-157 TB-500 cycle for tendon healing, suitable for most researchers in Canada:
- Weeks 1-2: BPC-157 250 mcg once daily. TB-500 2.5 mg twice weekly.
- Weeks 3-6: BPC-157 250 mcg twice daily (or 500 mcg once daily). TB-500 2.5-5 mg twice weekly.
- Weeks 7-8 (optional maintenance): BPC-157 250 mcg once daily. TB-500 2.5 mg once weekly.
Inject BPC-157 and TB-500 at different sites to avoid local irritation. Both can be injected subcutaneously into abdominal fat, but for tendon injuries many users inject near the affected area. Rotate injection sites to prevent bruising or lumps. Store reconstituted peptides in the refrigerator and use within 30 days for best stability.
Expected Results and Timeline
Most users report noticeable pain reduction within 2 to 3 weeks of starting the BPC-157 TB-500 cycle. Functional improvement, such as increased range of motion or load tolerance, typically appears by week 4. Full tendon remodeling may take 8 to 12 weeks, so a single 6-week cycle may not be enough for chronic or severe injuries. Some researchers run two back-to-back cycles with a 2-week break in between.
Clinical data on BPC-157 and TB-500 in humans is limited, but animal studies show accelerated tendon healing with both peptides. A 2019 study on rat Achilles tendons found that BPC-157 improved tensile strength and collagen organization. TB-500 has been shown to reduce inflammation and promote cell migration in tendon injury models. Anecdotal reports from Canadian users align with these findings, though individual results vary based on injury severity, age, and overall health.
Side Effects and Safety Considerations
Both BPC-157 and TB-500 are generally well tolerated in research settings. The most common side effects are mild injection site reactions such as redness, swelling, or itching. Some users report transient fatigue, headache, or nausea, especially at higher doses. No serious adverse events have been reported in human use, but long-term safety data is lacking.
Because these peptides are not approved by Health Canada for human use, they are sold for research purposes only. Anyone considering a BPC-157 TB-500 cycle should consult a healthcare provider, especially if they have a bleeding disorder, are pregnant, or take anticoagulant medications. For a deeper look at BPC-157 safety, see our article on BPC-157 side effects and safety profile.
Where to Get BPC-157 and TB-500 in Canada
In Canada, BPC-157 and TB-500 are available from online peptide suppliers that ship domestically. Prices vary, but a 5 mg vial of BPC-157 typically costs $40-70 CAD, while a 10 mg vial of TB-500 ranges from $60-100 CAD. A full 6-week cycle using 500 mcg of BPC-157 daily and 5 mg of TB-500 twice weekly would require about 21 mg of BPC-157 (roughly 4-5 vials) and 60 mg of TB-500 (6 vials), totaling approximately $500-800 CAD.
When choosing a supplier, look for third-party purity testing, clear labeling, and positive reviews from Canadian customers. Avoid vendors that do not provide certificates of analysis or that sell pre-mixed injectable solutions. Always reconstitute lyophilized powder yourself using bacteriostatic water.
For those in Quebec, our guide on purchasing BPC-157 5mg in Quebec lists verified suppliers and current prices.
Frequently Asked Questions
Can I use BPC-157 and TB-500 at the same time?
Yes, they are commonly stacked. Inject them at different times of day or different sites to minimize any interaction. There is no evidence of negative interaction between the two peptides.
How long should I cycle BPC-157 and TB-500?
A standard cycle is 4 to 8 weeks. For chronic tendon injuries, 8 weeks is often recommended, followed by a 2-4 week break before repeating if needed.
Is it better to inject near the injury or systemically?
Both methods work. Local injection may deliver a higher concentration to the injury site, but systemic injection is simpler and still effective. Many users inject subcutaneously near the tendon for localized injuries.
Do I need to load TB-500?
Some protocols include a loading phase of 5 mg twice weekly for the first 2 weeks, then drop to 2.5 mg twice weekly. This is optional and not clearly superior to a consistent dose.
Can I take BPC-157 orally for tendon healing?
Oral BPC-157 is available but less studied for tendon injuries. Injectable BPC-157 is preferred for localized musculoskeletal healing due to higher bioavailability at the target tissue.
Final Thoughts on the BPC-157 TB-500 Cycle
A BPC-157 TB-500 cycle is a promising research protocol for tendon healing, with a strong theoretical basis and growing anecdotal support. The recommended protocol is 250-500 mcg of BPC-157 daily plus 2.5-5 mg of TB-500 twice weekly for 4 to 8 weeks. Results typically begin within 2 to 3 weeks, with full benefits by 8 weeks. As with all research peptides, source from reputable Canadian suppliers and follow sterile injection practices.